Pharmacogenomics & Pharmacoproteomics

Pharmacogenomics & Pharmacoproteomics is the study of the use of genetics in drug response and provided DNA for genomes. It deals with the influence of acquired and inherited genetic variation on drug response in patients by Protein aggregation & stability in biopharmaceuticals, New discoveries in genomic targets, Various drug responses due to genetic polymorphisms, Drug dosage formulations, Drug safety and its efficiency and Membrane transport proteins. There are almost 3000 people from 60-65 universities in USA working for Proteomics. The NIH Pharmacogenomics Research Network (PGRN) is a network of scientists funding to PharmGKB since 2000.

  • Protein aggregation and stability in biopharmaceuticals
  • New discoveries in genomic targets
  • Various drug responses due to genetic polymorphisms
  • Drug dosage formulations
  • Drug safety and its efficacy
  • Membrane transport proteins

Related Conference of Pharmacogenomics & Pharmacoproteomics

June 26-28, 2017

3rd Glycobiology World Congress

London, UK
September 18-20, 2017

9th International Conference on Structural Biology

Zurich, Switzerland
September 21-22, 2017

International Conference on Glycobiology

Houston, Texas, USA
September 28-29, 2017

2nd International Conference on Biochemistry

Dubai, UAE
October 12-13, 2017

Global Proteomics Conference

Dubai, UAE
October 30 - November 01, 2017

3rd International Conference on Transcriptomics

Bangkok, Thailand
November 13-15, 2017

9th International Conference and Expo on Proteomics

Paris, France
November 13-14, 2017

9th International Conference on Bioinformatics

Paris, France
June 29-30, 2017

Conference on chemistry esc 2017

London

Pharmacogenomics & Pharmacoproteomics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in